IRIS Accounts Production v23.4.0.336 Other Company accounts True false Pounds 1.11.22 31.10.23 31.10.23 FY FRS 102 Independent examiner Large and medium-sized companies regime for accounts Full Charities SORP true true true true false true false true 0 0 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh092734132022-10-31092734132023-10-31092734132022-11-012023-10-31092734132021-10-31092734132021-11-012022-10-31092734132022-10-3109273413ns0:CharitableCompanyLimitedByGuarantee2022-11-012023-10-3109273413ns15:PoundSterling2022-11-012023-10-3109273413ns11:FRS1022022-11-012023-10-3109273413ns11:IndependentExaminationCharity2022-11-012023-10-3109273413ns11:LargeMedium-sizedCompaniesRegimeForAccounts2022-11-012023-10-3109273413ns11:FullAccounts2022-11-012023-10-3109273413ns11:CharitiesSORP2022-11-012023-10-3109273413ns16:EnglandWales2022-11-012023-10-3109273413ns11:RegisteredOffice2022-11-012023-10-3109273413ns0:Trustee22022-11-012023-10-3109273413ns0:Trustee32022-11-012023-10-3109273413ns0:Trustee42022-11-012023-10-3109273413ns0:Trustee12022-11-012023-10-3109273413ns10:WithinOneYear2023-10-3109273413ns10:WithinOneYear2022-10-3109273413ns0:TotalUnrestrictedFunds2023-10-310927341322022-11-012023-10-31
REGISTERED COMPANY NUMBER: 09273413 (England and Wales)
REGISTERED CHARITY NUMBER: 1162599



















Report of the Trustees and

Unaudited Financial Statements

for the Year Ended 31 October 2023

for

THE NEUROSURGICAL FOUNDATION

THE NEUROSURGICAL FOUNDATION

Contents of the Financial Statements
for the Year Ended 31 October 2023










Page

Report of the Trustees 1 to 5

Independent Examiner's Report 6

Statement of Financial Activities 7

Balance Sheet 8 to 9

Notes to the Financial Statements 10 to 14

THE NEUROSURGICAL FOUNDATION (REGISTERED NUMBER: 09273413)

Report of the Trustees
for the Year Ended 31 October 2023



The trustees who are also directors of the charity for the purposes of the Companies Act 2006, present their report with the financial statements of the charity for the year ended 31 October 2023. The trustees have adopted the provisions of Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).

OBJECTIVES AND ACTIVITIES
Objectives and aims
The Foundation's purpose as set out in the object in the charitable company's Memorandum Of Association is the advancement of neurosurgery for the public benefit and the benefit of the community generally.

The aims of the Foundation are:

-To publish an internationally-recognised Neurosurgical journal, consisting of peer-reviewed articles, case reports and editorial and educational articles;

-Thereby to advance and improve generally the education, knowledge and training among surgeons and other medical practitioners and all professions allied to health or concerned with the general health of the public generally having a qualification recognised by the National Health Service;

-To advance expertise, knowledge and understanding of neurosurgery by promotion and study of
Neurosurgery for the relief from sickness of persons suffering from neurological disorders;

-To facilitate and fund research and mentoring, tuition and advice and assistance generally for the relief of sickness of persons suffering from neurological disorders;

-To work for the benefit of the international community by assisting with funding of educational opportunities for both British and International Neurosurgeons and trainees.


THE NEUROSURGICAL FOUNDATION (REGISTERED NUMBER: 09273413)

Report of the Trustees
for the Year Ended 31 October 2023


ACHIEVEMENT AND PERFORMANCE
Charitable activities
TNF aims to support an increase in the bursary program, and pledges another £15,000 over and above £15,000 have been made available annually. This additional support will be reviewed annually depending upon the interest earned from the FD in coming years. The bursary support is £15,000 + £15,000 (£30,000) for the year 24-25.

TNF fully subsidies Associate Editor Development Program of BJNS.

TNF pledges to support in 24-25, a BJNS course on the development of excellence in scientific paper review and how to implement scientific evidence in clinical practice.


Report on Performance of British Journal of Neurosurgery

Submissions
There has been a steady decrease in submissions since 2021. This is partly due to the passing of the Covid peak. There is a move towards accepting only papers of good quality.

Acceptance rate
The acceptance rate for 2023 is 10%.

Journal Usage
The journal article usage remains comparable between 2022 and 2023. The articles are being accessed differently.

Impact factor
There has been a drop in the impact factor over the past two years. However, we are doing better when compared to peer journals.

Publication backlog
The publication backlog is 250 from 800 a year ago. The Impact Factor drop can be attributed to this.

Plagiarism
There has been an incident of plagiarism when one of our journal articles was used without acknowledgement. Specialist societies related to the authors have taken punitive actions.
The Nepalese Society have removed the author (fellow) from any positions within the Society. Cornell University has its legal team acting on the information.

AI tools
Taylor & Francis has produced a guideline on using AI Tools for submissions. The use of such a tool must be acknowledged.

Actions for 2024
BJNS editorial board to keep a record of editors appointed and an analysis be available.
BJNS will appoint a deputy editor.

THE NEUROSURGICAL FOUNDATION (REGISTERED NUMBER: 09273413)

Report of the Trustees
for the Year Ended 31 October 2023


We will continue our partnership with T&F and share the performance matrix during the board meeting in February.


Board Meetings
The Neurosurgical Foundation had two meetings of the board during 22-23. Minutes from these meetings are available.

Meeting 1: February 23
The board considered the charity's financial report and the journal's performance in the previous 12 months. A plan of action for the year 23-24 was discussed. Expanding TNF's charitable footprint of TNF, continuing to support the Associate Editor development program, addressing the publication backlog and maintaining the journal impact factor was the main focus.

Meeting 2: July 2023
The interim board meeting discussed and approved an investment of TNF reserve funds in a low-risk FD scheme. The investment policy of SBNS was adopted, which is an aligned charity. The investment returns were planned to expand bursaries through SBNS for The UK and Ireland neurosurgical trainees and medical students. A SBNS President's Bursary was started. All the bursaries align with the aims and objectives of the TNF charity.

The mid-year meeting also discussed the issue of payments made to the trustees. It was noted that the editor-in-chief of BJNS received payments equivalent to .5 PA over and above obligatory expenditures for services as the editor while holding the trustee position. This was per the decision in the TNF board meeting in October 2017. It is not apparent whether this payment is authorised in the charity's governing document. The board's subsequent submission to the Charity Commission to include a mention of this payment. It was also discussed that the BJNS editor and the deputy editor should be reimbursed for their time, and it should not be voluntary for the Editor to exclude himself during a discussion about pay.

FINANCIAL REVIEW
Principal funding sources
The Foundation's principal regular source of funds is its Journal royalties.

Investment policy and objectives
TNF has invested £280K in a 5% FD with HSBC. TNF charity aims to utilise the interest earned to increase bursaries available to UK and Ireland applicants of SBNS bursaries.

Reserves policy
The Foundation seeks to maintain its uncommitted reserves at five times its annual standing costs. This amount is £60K

FUTURE PLANS
Supporting SBNS bursaries for UK and Irish neurosurgical workforce of the future. A total of around £30,000 was made available in 23-24. The whole pledge was not utilised.


THE NEUROSURGICAL FOUNDATION (REGISTERED NUMBER: 09273413)

Report of the Trustees
for the Year Ended 31 October 2023


STRUCTURE, GOVERNANCE AND MANAGEMENT
Governing document
The charity is controlled by its governing document, a deed of trust, and constitutes a limited company, limited by guarantee, as defined by the Companies Act 2006.

The Foundation is a charitable company limited by guarantee as defined by the Companies Act 2006,
Incorporated on 21 October 2014 and registered as a charity on 9 July 2015. The Foundation's objects and powers were established by its Memorandum and it is governed under its Articles of Association.

Recruitment and appointment of new trustees
For charity law, the Foundation's trustees are the directors of the charitable company who are the elected Officers of the Foundation.

The Editor of the BJNS will remit his role as a trustee. The editor will continue as a member of the board.

REFERENCE AND ADMINISTRATIVE DETAILS
Registered Company number
09273413 (England and Wales)

Registered Charity number
1162599

Registered office
7 Swallow Place
London
W1B 2AG

Trustees
N D Mendoza Consultant (resigned 23.4.2023)
Professor M D Jenkinson
N Mukerji
S Basu (appointed 23.4.2023)

In addition, Sue Woodward is a lay member on the committee, providing a non-medical opinion in board meetings.

Independent Examiner
Mr Ryan Cottington, ACA
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB

Approved by order of the board of trustees on 1 April 2024 and signed on its behalf by:



THE NEUROSURGICAL FOUNDATION (REGISTERED NUMBER: 09273413)

Report of the Trustees
for the Year Ended 31 October 2023





S Basu - Trustee

Independent Examiner's Report to the Trustees of
The Neurosurgical Foundation


Independent examiner's report to the trustees of The Neurosurgical Foundation ('the Company')
I report to the charity trustees on my examination of the accounts of the Company for the year ended 31 October 2023.

Responsibilities and basis of report
As the charity's trustees of the Company (and also its directors for the purposes of company law) you are responsible for the preparation of the accounts in accordance with the requirements of the Companies Act 2006 ('the 2006 Act').

Having satisfied myself that the accounts of the Company are not required to be audited under Part 16 of the 2006 Act and are eligible for independent examination, I report in respect of my examination of your charity's accounts as carried out under Section 145 of the Charities Act 2011 ('the 2011 Act'). In carrying out my examination I have followed the Directions given by the Charity Commission under Section 145(5) (b) of the 2011 Act.

Independent examiner's statement
I have completed my examination. I confirm that no matters have come to my attention in connection with the examination giving me cause to believe:

1. accounting records were not kept in respect of the Company as required by Section 386 of the 2006 Act; or
2. the accounts do not accord with those records; or
3. the accounts do not comply with the accounting requirements of Section 396 of the 2006 Act other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination; or
4. the accounts have not been prepared in accordance with the methods and principles of the Statement of Recommended Practice for accounting and reporting by charities (applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102)).

I have no concerns and have come across no other matters in connection with the examination to which attention should be drawn in this report in order to enable a proper understanding of the accounts to be reached.








Mr Ryan Cottington, ACA

Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB

1 April 2024

THE NEUROSURGICAL FOUNDATION

Statement of Financial Activities
for the Year Ended 31 October 2023

2023 2022
Unrestricted Total
fund funds
Notes £    £   
INCOME AND ENDOWMENTS FROM
Charitable activities
Royalties 35,530 36,891
Editorial income 22,283 22,282
Meeting income - 2,000

Investment income 2 3,627 -
Total 61,440 61,173

EXPENDITURE ON
Charitable activities
Editorial expenses 22,399 14,392

Other 2,568 2,280
Total 24,967 16,672

NET INCOME 36,473 44,501


RECONCILIATION OF FUNDS
Total funds brought forward 340,263 295,762

TOTAL FUNDS CARRIED FORWARD 376,736 340,263

THE NEUROSURGICAL FOUNDATION (REGISTERED NUMBER: 09273413)

Balance Sheet
31 October 2023

2023 2022
Unrestricted Total
fund funds
Notes £    £   
CURRENT ASSETS
Debtors 5 47,980 49,165
Cash at bank 331,121 293,323
379,101 342,488

CREDITORS
Amounts falling due within one year 6 (2,365 ) (2,225 )

NET CURRENT ASSETS 376,736 340,263

TOTAL ASSETS LESS CURRENT LIABILITIES 376,736 340,263

NET ASSETS 376,736 340,263
FUNDS 7
Unrestricted funds 376,736 340,263
TOTAL FUNDS 376,736 340,263

The charitable company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 October 2023.


The members have not required the company to obtain an audit of its financial statements for the year ended 31 October 2023 in accordance with Section 476 of the Companies Act 2006.


The trustees acknowledge their responsibilities for
(a)ensuring that the charitable company keeps accounting records that comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the charitable company as at the end of each financial year and of its surplus or deficit for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the charitable company.


THE NEUROSURGICAL FOUNDATION (REGISTERED NUMBER: 09273413)

Balance Sheet - continued
31 October 2023

These financial statements have been prepared in accordance with the provisions applicable to charitable companies subject to the small companies regime.


The financial statements were approved by the Board of Trustees and authorised for issue on 1 April 2024 and were signed on its behalf by:





S Basu - Trustee

THE NEUROSURGICAL FOUNDATION

Notes to the Financial Statements
for the Year Ended 31 October 2023


1. ACCOUNTING POLICIES

Basis of preparing the financial statements
The financial statements of the charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Income
All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably.

Expenditure
Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

Grants offered subject to conditions which have not been met at the year end date are noted as a commitment but not accrued as expenditure.

Taxation
The charity is exempt from corporation tax on its charitable activities.

Fund accounting
Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes.

Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.


THE NEUROSURGICAL FOUNDATION

Notes to the Financial Statements - continued
for the Year Ended 31 October 2023


2. INVESTMENT INCOME
2023 2022
£    £   
Deposit account interest 3,627 -

3. TRUSTEES' REMUNERATION AND BENEFITS

There were no trustees' remuneration or other benefits for the year ended 31 October 2023 nor for the year ended 31 October 2022.


Trustees' expenses

During the year no expenses were paid to Trustees ( 2022 - no expenses paid).

4. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES
Unrestricte
fund
£   
INCOME AND ENDOWMENTS FROM
Charitable activities
Royalties 36,891
Editorial income 22,282
Meeting income 2,000
Total 61,173

EXPENDITURE ON
Charitable activities
Editorial expenses 14,392

Other 2,280
Total 16,672

NET INCOME 44,501


RECONCILIATION OF FUNDS
Total funds brought forward 295,762

TOTAL FUNDS CARRIED FORWARD 340,263

THE NEUROSURGICAL FOUNDATION

Notes to the Financial Statements - continued
for the Year Ended 31 October 2023


5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Trade debtors 47,980 49,165

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2023 2022
£    £   
Accruals and deferred income 2,365 2,225

7. MOVEMENT IN FUNDS
Net
At movement At
1/11/22 in funds 31/10/23
£    £    £   
Unrestricted funds
General fund 340,263 36,473 376,736

TOTAL FUNDS 340,263 36,473 376,736

Net movement in funds, included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£    £    £   
Unrestricted funds
General fund 61,440 (24,967 ) 36,473

TOTAL FUNDS 61,440 (24,967 ) 36,473


THE NEUROSURGICAL FOUNDATION

Notes to the Financial Statements - continued
for the Year Ended 31 October 2023


7. MOVEMENT IN FUNDS - continued

Comparatives for movement in funds

Net
At movement At
1/11/21 in funds 31/10/22
£    £    £   
Unrestricted funds
General fund 295,762 44,501 340,263

TOTAL FUNDS 295,762 44,501 340,263

Comparative net movement in funds, included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£    £    £   
Unrestricted funds
General fund 61,173 (16,672 ) 44,501

TOTAL FUNDS 61,173 (16,672 ) 44,501

A current year 12 months and prior year 12 months combined position is as follows:

Net
At movement At
1/11/21 in funds 31/10/23
£    £    £   
Unrestricted funds
General fund 295,762 80,974 376,736

TOTAL FUNDS 295,762 80,974 376,736

THE NEUROSURGICAL FOUNDATION

Notes to the Financial Statements - continued
for the Year Ended 31 October 2023


7. MOVEMENT IN FUNDS - continued

A current year 12 months and prior year 12 months combined net movement in funds, included in the above are as follows:

Incoming Resources Movement
resources expended in funds
£    £    £   
Unrestricted funds
General fund 122,613 (41,639 ) 80,974

TOTAL FUNDS 122,613 (41,639 ) 80,974

8. RELATED PARTY DISCLOSURES

There were no related party transactions for the year ended 31 October 2023.